Welcome to the Center for Sickle Cell Disease

Sickle Cell Adult Transition Website

Transitioning from pediatric to adult providers is an essential step in the care of teens and young adults with sickle cell anemia. The Howard University, Center for Sickle Cell Disease, Adult Transition Program works to educate children and young adults about their disease and personal medical history and develop skill sets required to navigate the adult health care setting.
 Learn more HERE

 

Howard University's Center for Sickle Cell Disease (SCD) was founded by the late Dr. Roland B. Scott in 1971 to address the needs of patients and families in the Washington Metropolitan area affected by SCD. The Center is committed to a six-fold goal that includes comprehensive medical care, research, testing, education, counseling, and community outreach. Recently, the Center has expanded its clinical research program and developed a collaborative consortium with Children’s National Medical Center (CNMC) and in working together with Howard University Hospital and NIH we are the Washington area’s leading provider of patient services for SCD.

8th Annual Stomp Out Sickle Cell Walk

September 20, 2014 from 7:00am –Noon
On the DC National Mall - near 14th St., NW
between Jefferson and Madison Sts.

Register for this event today! We need you to
make the SOS Walk a success. Encourage
your family, friends and colleagues to join you.
Make a team and make a difference!

Download the full schedule!

 

*************************************************************************

 

Learn About the History of Sickle Cell Disease

A Brief History of Sickle Cell Disease by William P. Winter, Ph.D.

*************************************************************************

Sickle Cell and Anemia News (Archive)

  • Sickle Cell Disease In Adults Reversed By Blood Stem-Cell Transplant Regimen. A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine. The trial was conducted at the NIH Clinical Center in Bethesda, Md., by NIH researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases. News from NIH News (posted December 9, 2009).

*** CLICK HERE TO JOIN US ON FACEBOOK! ***

 

Last updated: September 15, 2014